Scarica l'app Stockscreener
9.86
5.79%
0.54
Precedente Chiudi:
$9.32
Aprire:
$9.33
Volume 24 ore:
34,814
Relative Volume:
0.82
Capitalizzazione di mercato:
$159.01M
Reddito:
-
Utile/perdita netta:
$-33.82M
Rapporto P/E:
-0.3853
EPS:
-25.5891
Flusso di cassa netto:
$-66.04M
1 W Prestazione:
+8.95%
1M Prestazione:
+22.94%
6M Prestazione:
+36.94%
1 anno Prestazione:
+110.23%
Intervallo 1D:
$9.33
$10.28
Intervallo di 1 settimana:
$9.1399
$10.28
Portata 52W:
$3.70
$10.28
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Nome
Elicio Therapeutics Inc
Settore
Industria
Telefono
(857) 209-0050
Indirizzo
451 D STREET, 5TH FLOOR, BOSTON
Confronta ELTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
9.94 | 147.01M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.84 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.20 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.99 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
573.02 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.03 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Elicio Therapeutics Inc Borsa (ELTX) Ultime notizie
What drives Elicio Therapeutics Inc. stock priceOutstanding stock performance - Autocar Professional
What analysts say about Elicio Therapeutics Inc. stockConsistent high-performance stocks - jammulinksnews.com
When the Price of (ELTX) Talks, People Listen - news.stocktradersdaily.com
Is Elicio Therapeutics Inc. a good long term investmentExponential wealth increase - jammulinksnews.com
How Elicio Therapeutics Inc. stock performs during market volatilityWeekly Double Return List - Newser
Elicio Therapeutics Inc. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com
Elicio Therapeutics: Promising Trial Results and Commercial Potential Drive Buy Rating - TipRanks
H.C. Wainwright raises Elicio Therapeutics stock price target to $13 on trial outlook By Investing.com - Investing.com South Africa
H.C. Wainwright raises Elicio Therapeutics stock price target to $13 on trial outlook - Investing.com Australia
Elicio Therapeutics: HC Wainwright Raises PT to $13, Maintains Buy Rating - AInvest
What makes Elicio Therapeutics Inc. stock price move sharplyFree Signals Group - Newser
Why Elicio Therapeutics Inc. stock attracts strong analyst attentionTop Performer Shortlist - Newser
Trend Tracker for (ELTX) - news.stocktradersdaily.com
Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) market cap up US$12m last week, benefiting both retail investors who own 47% as well as insiders - simplywall.st
When (ELTX) Moves Investors should Listen - news.stocktradersdaily.com
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) dropped from Russell 3000E Growth Index - MarketScreener
JonesTrading Remains a Buy on Elicio Therapeutics (ELTX) - The Globe and Mail
Is Elicio Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Elicio Therapeutics Secures Strategic Financing As Pivotal Cancer Trial Data Approaches - Barchart.com
Elicio Therapeutics to Host Virtual KOL Event on June 25, - GlobeNewswire
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer - GlobeNewswire Inc.
Elicio secures $10 million to extend cash runway By Investing.com - Investing.com South Africa
Elicio Therapeutics Secures $10 Million in Financing - citybiz
Elicio Therapeutics Gets $10 Million Note Financing - marketscreener.com
Elicio secures $10 million to extend cash runway - Investing.com
Elicio Therapeutics Secures $10M Financing for Operations - TipRanks
Elicio Therapeutics (ELTX) Secures $10M Financing to Extend Operations | ELTX Stock News - GuruFocus
Elicio Therapeutics Lands $10M Funding to Advance Revolutionary Cancer Vaccine Through Critical Trial Phase - Stock Titan
Elicio Therapeutics announces board election results By Investing.com - Investing.com Nigeria
Elicio Therapeutics Elects New Directors at Annual Meeting - TipRanks
Elicio Therapeutics announces board election results - Investing.com
Elicio Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Elicio's (ELTX) ELI-002 Interim Analysis Anticipated in Phase 2 Trial | ELTX Stock News - GuruFocus
Elicio Therapeutics: Q1 Earnings Snapshot - CTPost
Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
Elicio Therapeutics Inc Azioni (ELTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.15%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):